Cargando…
Application of the amplification-free SERS-based CRISPR/Cas12a platform in the identification of SARS-CoV-2 from clinical samples
The control of contagious or refractory diseases requires early, rapid diagnostic assays that are simple, fast, and easy-to-use. Here, easy-to-implement CRISPR/Cas12a-based diagnostic platform through Raman transducer generated by Raman enhancement effect, term as SERS-CRISPR (S-CRISPR), are describ...
Autores principales: | Liang, Jiajie, Teng, Peijun, Xiao, Wei, He, Guanbo, Song, Qifang, Zhang, Ying, Peng, Bin, Li, Gan, Hu, Liangshan, Cao, Donglin, Tang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424404/ https://www.ncbi.nlm.nih.gov/pubmed/34496881 http://dx.doi.org/10.1186/s12951-021-01021-0 |
Ejemplares similares
-
Platinum nanoparticles (PtNPs)-based CRISPR/Cas12a platform for detection of nucleic acid and protein in clinical samples
por: Liang, Jiajie, et al.
Publicado: (2022) -
One-pot platform for rapid detecting virus utilizing recombinase polymerase amplification and CRISPR/Cas12a
por: Xiong, Yifan, et al.
Publicado: (2022) -
Amplification-free RNA detection with CRISPR–Cas13
por: Shinoda, Hajime, et al.
Publicado: (2021) -
CRISPR-Cas, Argonaute proteins and the emerging landscape of amplification-free diagnostics
por: Santiago-Frangos, Andrew, et al.
Publicado: (2022) -
CRISPR/Cas12a Technology Combined with Recombinase Polymerase Amplification for Rapid and Portable Monkeypox Virus Detection
por: Li, Feifei, et al.
Publicado: (2023)